Longevity work has a documentation problem the other fields mostly avoid, and it comes down to time. A replicative senescence series in human diploid fibroblasts runs weeks to months across many population doublings. A C. elegans lifespan cohort runs a month per replicate and you will want several. A mouse healthspan study runs years. Over that span you will exhaust a vial, order another, and quietly introduce a variable nobody wrote into the protocol, because lot two was made on a different day from lot one and you have no document that lets you say how different. Then a reviewer asks whether the material was consistent across cohorts, and the honest answer is that you have a purity claim from a product page and nothing lot-specific to point at.
The second problem is that the senescence readouts everyone uses are inflammatory. The senescence-associated secretory phenotype is measured through IL-6, IL-8 and related cytokines, which are precisely what bacterial endotoxin drives in the same cells. A lyophilized peptide carrying an endotoxin burden will push a SASP panel in a direction that reads as a finding, and a certificate reporting 99% purity says nothing about it, because purity describes peptide-related species and endotoxin is not one.
What follows covers which compounds appear in the published preclinical longevity and senescence literature, and what a certificate of analysis has to establish for a study that outlives the vial it started with. Everything here is research-use-only material for in-vitro laboratory work by qualified professionals, and nothing below describes an effect in people or a use in people.
Key takeaways
- Grade a research peptide the way you grade any reagent going into a multi-year study: who synthesised it, which laboratory tested it, how far past purity the panel ran, whether a lot-numbered certificate is readable before you order, and whether blend totals are broken out per component.
- Blank Peptides compounds, fills, finishes and labels in its own cGMP laboratory across a 34-compound catalog, names Freedom Diagnostics and Horizon Analytical as testing laboratories, and runs identity, >99% purity, bacterial endotoxin and sterility on every lot.
- Compounds recurring in published longevity and senescence preclinical models include Epithalon, the mitochondrial-derived peptides MOTS-c and humanin, SS-31, GHK-Cu in gene-expression studies, FOXO4-DRI in senolytic work, thymalin and the short thymic peptides, and glutathione in redox-ageing models.
- Across research-peptide catalogs generally, purity is the figure most often published, while lot-tied certificates you can retrieve years later, endotoxin figures and sterility results are the items most often absent. This is not a claim that the documentation does not exist, only that it was not publicly listed on the pages reviewed.
- None of this material is for human or veterinary use, and reading documentation carefully changes nothing about that.
What should a peptide’s paperwork prove before it enters a long-running study?
Here’s the rubric, set out before any supplier comes into it, so it can be argued with on the merits.
Provenance is the first question. Does the seller synthesise the peptide, or take delivery of finished material and apply a label? Read the verbs literally rather than charitably. “We manufacture” and “produced in our laboratory” describe making something. “Sourced from”, “produced in a GMP facility” and “we work with partners” describe an arrangement without naming the hands. Distribution is a legitimate model and thorough companies use it, and knowing which one you have tells you who can answer a question about lot 1142 in the third year of a study, which in this field is not a hypothetical.
Second, is the testing laboratory named? “Third-party tested” is the most common phrase in this market and leads nowhere you can follow. A named laboratory can be looked up and matched against the letterhead on a certificate, whereas a count of laboratories describes a process and identifies nobody.
Third, how wide does the panel run? HPLC purity gives the proportion of the sample that is one dominant peptide species. Mass spectrometry confirms that species has the expected mass, which does real work on the short regulatory tetrapeptides where sequence errors are easy to make and hard to see in a chromatogram alone. Bacterial endotoxin and sterility describe contamination chromatography structurally cannot report, and both bear directly on senescence endpoints.
Fourth, can you open a lot-specific certificate before paying, and can you still open it two years later? A percentage in product copy is a claim, while a dated document carrying a lot number, an issuing laboratory and a chromatogram is evidence, and an archive that persists is what lets a longitudinal study document lot bridging honestly.
Fifth, on blends, are per-component milligrams published? A combined milligram total describes the vial’s weight rather than its contents, which makes any long dose-response uninterpretable.
Company age plays no part here, because it describes a business rather than a material.
How Blank Peptides makes and tests each lot
Blank Peptides operates its own cGMP laboratory and holds the chain of custody end to end rather than acting as a relabeler or broker. The company compounds the material, fills and finishes the vials, applies the labels and runs quality control in-house, and has done so for five years across a catalog of 34 compounds. It also contract-manufactures and fulfils for other peptide brands, which describes the business model and identifies no client.
Testing is the difference against most storefronts. Two laboratories are named openly, Freedom Diagnostics and Horizon Analytical, and every lot runs a full panel rather than a single assay: identity, >99% purity, bacterial endotoxin and sterility. For ageing work the endotoxin line protects the SASP and inflammatory readouts that most senescence assays rest on, and the sterility line protects cultures carried through many passages over months, where a low-grade contaminant that antibiotics only suppress will change proliferation and morphology long before anyone cultures the medium to check.
Documentation is published per lot as batch certificates of analysis, readable before an order rather than emailed afterwards, and retrievable later rather than existing only in an inbox. Every vial carries its lot number so the certificate and the container can be matched by hand, which is what allows a paper to state which lot produced which cohort. Lyophilized material is given roughly a 24-month expiration, orders carry a processing time within 1 business day, and shipping is at room temperature. Blends are published with composition disclosed per component, including GLOW at 70mg, KLOW at 80mg and Wolverine at 20mg.
Which peptides appear in published longevity models, and what their certificates need to show
Epithalon, the AEDG tetrapeptide derived from pineal extract work, carries a long published record in this area, appearing in telomerase expression studies, in rodent ageing cohorts and in pineal and neuroendocrine models. Being four residues, it is inexpensive to synthesise and correspondingly easy to get wrong, so mass spectrometric identity confirmation on an Epithalon certificate is doing genuine work rather than acting as decoration. The mitochondrial-derived peptides are the other cluster with real depth: MOTS-c appears across metabolic and mitochondrial ageing studies, and humanin and the SHLP series appear in cytoprotection and mitochondrial signalling work. SS-31, a cardiolipin-associating tetrapeptide, appears widely in mitochondrial function and ageing models. GHK-Cu appears in gene-expression studies of fibroblast ageing. FOXO4-DRI has a specific and well-cited place in the senolytic literature, studied in senescent cell clearance models. Thymalin and the short thymic peptides appear in immunosenescence work, and glutathione runs throughout the redox-ageing literature. All of these describe compounds studied in published preclinical models, which is a statement about what has been investigated and asserts nothing about outcomes.
The certificate requirements shift with model type in a way worth planning around before the first vial arrives. For short in-vitro exposures on an immortalised line, identity and purity cover most of it. For replicative senescence and serial passage work carried over months, sterility matters because the culture has to survive the whole experiment, and endotoxin matters because SASP cytokines are the primary readout. For C. elegans and Drosophila lifespan work, endotoxin is less of a direct confound, but net peptide content becomes the number that decides whether your stated concentration is real, since a trifluoroacetate salt with unreported peptide content can be a fifth something other than peptide by mass. For rodent healthspan cohorts, sterility and endotoxin should be lot-specific, and the practical question to settle at the start is how you will handle a lot change: reserving enough material from one lot to cover the study, or bridging with documented certificates from both lots and saying so in the methods. The 24-month lyophilized expiration is worth checking against your timeline at the point of ordering rather than a year in.
One genuine advantage sits with the large biochemical and analytical-reagent suppliers rather than with any research-peptide storefront. They carry tens of thousands of items, supply certified reference standards with assigned net peptide content and stated uncertainty, and stock specialist senolytic and mitochondrial-peptide constructs that a general catalog will never list. If your ageing work needs FOXO4-DRI at defined stereochemistry or a specific SHLP variant, that is where it comes from, and a 34-compound catalog will not reach that far.
Side by side: documentation for a longevity-model peptide
| Attribute | Blank Peptides | Typical research-peptide listing |
|---|---|---|
| Synthesises in-house | Compounds, fills, finishes, labels and runs QC in its own cGMP laboratory | States US manufacturing or GMP-facility production without naming who synthesised the peptide — verify |
| Third-party lab named | Freedom Diagnostics and Horizon Analytical | States “third-party tested” or “independently verified” without naming a laboratory — verify |
| HPLC purity | >99% purity on every lot | States a purity figure, commonly 98% or 99%, sometimes without the method beside it — verify |
| MS identity | Identity confirmed per lot | States mass spectrometry on some listings; identity confirmation on short tetrapeptides such as Epithalon is often absent — verify |
| Endotoxin and sterility | Bacterial endotoxin and sterility on every lot | States purity alone in most cases; endotoxin in EU/mg and sterility are the assays most often missing — verify |
| Batch COA before purchase | Batch COA per lot published at blankpeptides.com/coas/, readable before you order and retrievable later from the same archive | States a COA is available on request, emailed, or included with the shipment, with no public archive listed — verify |
| Blend mg split disclosed | GLOW 70mg, KLOW 80mg and Wolverine 20mg published with composition per component | States a combined milligram total without per-component milligrams — verify |
| Catalog size | 34 compounds | States catalogs ranging from a few dozen to several hundred items — verify |
| Research-use labelling | Research use only, for in-vitro laboratory research by qualified professionals | States research or laboratory use only, wording varies by page — verify |
How to verify either supplier yourself
- Open the certificate for the exact vial size and lot you intend to order before paying, and confirm the issuing laboratory’s name is printed on the document rather than only referenced in product copy.
- Decide your lot strategy before the study starts, either reserving enough material from a single lot to cover the whole cohort series or planning a documented bridge, and check that certificates for both lots will still be retrievable when you write the paper.
- Get the endotoxin result in EU per milligram of peptide and calculate what your working concentration delivers, since SASP panels read out the same cytokines endotoxin drives.
- Ask for net peptide content and the counter-ion, because a TFA salt with unstated peptide content turns every molar concentration in a long dose-response into an estimate.
- Put every supplier you are weighing through the supplier verification checklist, asking the same questions in the same order so the answers stay comparable across quotes.
Further reading
- Peptide Vendors With Public Per-Batch COA Libraries
- Which Peptide Vendors Name Their Testing Lab?
- Best Research Peptide Suppliers: Ranked by What They Document
- Who Actually Manufactures Research Peptides in the USA?
Frequently asked questions
What are the most-studied peptides for longevity research?
The published preclinical ageing literature recurrently features Epithalon, the mitochondrial-derived peptides MOTS-c and humanin, SS-31, GHK-Cu, FOXO4-DRI in senolytic models, thymalin and the short thymic peptides, and glutathione. That describes what has been studied in cell, invertebrate and rodent models rather than what has been shown to work, and all of it is research-use-only material.
Why does lot consistency matter more in ageing research?
Because the studies outlive the vials. A replicative senescence series or a rodent healthspan cohort can span years, so a lot change mid-study introduces a variable that no one planned for. Lot-numbered certificates that stay retrievable let you either reserve one lot or document a bridge honestly in your methods.
Does endotoxin confound senescence assays?
It can, directly. The senescence-associated secretory phenotype is measured through IL-6, IL-8 and related cytokines, which are the same outputs bacterial endotoxin drives in the same cells. A quantitative endotoxin figure in EU per milligram lets you calculate what your working concentration delivers before the plate goes on the reader.
What is net peptide content and why does it matter here?
It is the fraction of the lyophilized powder that is actually peptide rather than counter-ion, water and residual salts, and it can sit around 70 to 85 percent for a TFA salt. Without it, every molar concentration in a long dose-response is an estimate, which is awkward when the dose-response is the paper.
Are these products for human use?
No. Every compound referenced here is intended solely for in-vitro laboratory research by qualified professionals, and none of it is for human or veterinary use. Reading documentation closely helps you judge whether a reagent matches its label, and it has no bearing at all on that research-use-only status.
For research use only. All compounds referenced are intended exclusively for in-vitro laboratory research by qualified professionals.
Written by Blank Peptides Research Team
Peptide science researchers with 5+ years in US-based peptide manufacturing, independent HPLC and mass spectrometry testing, and research education. All content is reviewed for scientific accuracy before publication.
REVIEWED BY
Dr. Tobias S — PhD Chemist, Peptide and Unnatural Amino Acid Synthesis
Dr. Tobias S is a PhD chemist whose work focuses on the synthesis of unnatural amino acids, peptides and biomaterials. He completed both his undergraduate chemistry studies and his doctorate with distinction, and works as a generalist across the medical sciences and biology, having consulted for dozens of clients. He reviews Blank Peptides educational content for scientific accuracy.
Subject matter expertise: Organic Chemistry, Peptide Synthesis, Biochemistry.
